Daniel M. Chambers

Mr. Chambers owns the Biotechnology Law Group, which he founded in May 2002 after more than 10 years of practicing as an attorney in both corporate and law firm settings. Mr. Chambers has been registered to practice before the U.S. Patent and Trademark Office since 1990, and he is admitted to practice law in California. He has extensive legal experience relating to patents, opinion letters, and licensing. His research experience draws from his training in biology (BA; University of California, Los Angeles (1985)) and more than four years of molecular biology-based research in academia (UCLA and Duke, 1985-1988) and industry (Amgen, 1988-1989).

With regard to patents, Mr. Chambers has substantial experience in various fields relevant to biotechnology and pharmaceuticals, including molecular biology, immunology, gene therapy, and chemistry, as well as other technology areas, principally medical devices and automotives. His clients have included Amgen, where he served first as a patent agent and then as corporate counsel; Viagene, where he was the Company’s sole in-house attorney, GeneFormatics, where he served as Vice President, Intellectual Property and then as General Counsel, as well as SUGEN, Gen-Probe, Geron, Biosite, Wyntek Diagnostics, and Cardiothoracic Systems, which he represented while in private practice at Lyon & Lyon and Brobeck. In this context, Mr. Chambers has provided the full range of services, from implementing invention identification and tracking mechanisms to counseling inventors, drafting and prosecuting patent applications (including interference practice), and handling post-issuance proceedings.

In addition to his extensive prosecution experience, Mr. Chambers has also prepared many patentability, non-infringement, validity, and freedom to operate opinions.

Mr. Chambers also has extensive experience in licensing matters, ranging from assisting start-up clients in developing a basic set of standard form agreements (e.g., 1- and 2-way non-disclosure agreements, material transfer agreements, consulting agreements, etc.) to multi-million dollar strategic collaboration agreements. His expertise in this area includes not only drafting definitive agreements, but also in the strategic conception and negotiation of the relevant business and legal issues.

Mr. Chambers is a member of the American Bar Association, Licensing Executive Society (LES), American Intellectual Property Law Association (AIPLA), and San Diego Intellectual Property Law Association (SDIPLA). Outside of the practice of law, Mr. Chambers enjoys spending time with his wife and children, automobiles and racing, exercising regularly, woodworking, and traveling. He can be reached directly at 858.350.9690 or dan@biotechnologylawgroup.com.